Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Morris R. Jenner"'
Autor:
Morris R. Jenner, Stuart Brink, Martha Spencer, Kusiel Perlman, Hilary Kitson, Rocco L. Brunelle, Larry C. Deeb, John H. Holcombe, Sunita Zalani
Publikováno v:
Pediatrics. 108:1175-1179
Objective. This study compared the glucose-lowering effect of insulin lispro, given before or after meals, with regular human insulin given before meals in prepubertal children with diabetes. Research Design and Methods. A 3-way crossover, open-label
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18f200eb53cba3d18479b5473709044
https://doi.org/10.1542/peds.108.5.1175
https://doi.org/10.1542/peds.108.5.1175
Autor:
Jeffrey L. Mahon, Cameron Purdon, John Dupre, Morris R. Jenner, N Wilson Rodger, Calvin R. Stiller
Publikováno v:
Diabetes. 40:598-604
We have studied the endocrine-metabolic status of patients in non–insulin-receiving (NIR) remission of insulin-dependent diabetes mellitus (IDDM) within 6–60 mo of diagnosis during administration of cyclosporine, in comparison with nondiabetic su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7d8ec2a6ef662046eb17e84e7a1b489
https://doi.org/10.2337/diab.40.5.598
https://doi.org/10.2337/diab.40.5.598
Autor:
Calvin R. Stiller, Jeffrey L. Mahon, Morris R. Jenner, Paul R. Atkinson, Clement I Momah, Terri Paul, John Dupré
Publikováno v:
Journal of Autoimmunity. 3:793-799
Although cyclosporine A (Cy-A) is effective in modifying the initial course of newly diagnosed insulin dependent diabetes mellitus (IDDM) it has a number of side effects, particularly renal, which limit its use. In this study we investigated the pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4221f4f034a06dc662275ce4d350fd6
https://doi.org/10.1016/s0896-8411(05)80045-9
https://doi.org/10.1016/s0896-8411(05)80045-9
Publikováno v:
Annals of Internal Medicine. 104:660
Excerpt The clinical introduction of cyclosporine heralded a new class of immunoregulatory drugs with specific inhibitory effects on T-cell functions and elaborated products (1, 2). Cyclosporine's ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7ec9d70c4b11b2a98738b197c6202e
https://doi.org/10.7326/0003-4819-104-5-660
https://doi.org/10.7326/0003-4819-104-5-660